创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

朱晓雨, 白一丹, 李思谦, 柳文媛. 藤苦参强心苷抗肿瘤作用研究进展[J]. 药学进展, 2018, 42(6): 459-465.
引用本文: 朱晓雨, 白一丹, 李思谦, 柳文媛. 藤苦参强心苷抗肿瘤作用研究进展[J]. 药学进展, 2018, 42(6): 459-465.
ZHU Xiaoyu, BAI Yidan, LI Siqian, LIU Wenyuan. Research Progress in Antitumor Effects of Cardiac Glycosides from Streptocaulon griffithii[J]. Progress in Pharmaceutical Sciences, 2018, 42(6): 459-465.
Citation: ZHU Xiaoyu, BAI Yidan, LI Siqian, LIU Wenyuan. Research Progress in Antitumor Effects of Cardiac Glycosides from Streptocaulon griffithii[J]. Progress in Pharmaceutical Sciences, 2018, 42(6): 459-465.

藤苦参强心苷抗肿瘤作用研究进展

Research Progress in Antitumor Effects of Cardiac Glycosides from Streptocaulon griffithii

  • 摘要: 藤苦参为萝藦科植物,其主要成分为强心苷类化合物。藤苦参的抗肿瘤作用近年来逐渐受到关注。综述藤苦参中分离出的强心苷的化学结构、抗肿瘤活性、构效关系及作用机制等方面的研究进展,以期为藤苦参抗肿瘤药效成分的深入研究提供参考。

     

    Abstract: Streptocaulon griffithii belongs to family Asclepiadaceae, and its major constituents are cardiac glycosides. Streptocaulon griffithii has attracted great attention for its antitumor effect in recent years. This review summarized the research progress in the chemical structures, antitumor effects, structure-activity relationship and mechanisms of action of cardiac glycosides from Streptocaulon griffithii, so as to provide reference for further investigation on the bioactive components with anti-tumor potential in Streptocaulon griffithii.

     

/

返回文章
返回